Capital Advantage’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
|
|||||
|
2025
Q1 | $395K | Hold |
|
|||||
|
2024
Q4 | $395K | Sell |
|
|||||
|
2024
Q3 | $587K | Sell |
|
|||||
|
2024
Q2 | $615K | Buy |
|
|||||
|
2024
Q1 | $626K | Sell |
|
|||||
|
2023
Q4 | $640K | Sell |
|
|||||
|
2023
Q3 | $832K | Buy |
|
|||||
|
2023
Q2 | $876K | Sell |
|
|||||
|
2023
Q1 | $1.01M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Sell |
|
|||||
|
2022
Q3 | $1.05M | Buy |
|
|||||
|
2022
Q2 | $1.16M | Sell |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $1.19M | Buy |
|
|||||
|
2021
Q3 | $926K | Buy |
|
|||||
|
2021
Q2 | $842K | Sell |
|
|||||
|
2021
Q1 | $779K | Buy |
|
|||||
|
2020
Q4 | $735K | Sell |
|
|||||
|
2020
Q3 | $708K | Sell |
|
|||||
|
2020
Q2 | $638K | Sell |
|
|||||
|
2020
Q1 | $730K | Buy |
|
|||||
|
2019
Q4 | $718K | Sell |
|
|||||
|
2019
Q3 | $668K | Buy |
|
|||||
|
2019
Q1 | $696K | Buy |
|
|||||
|
2018
Q4 | $650K | Buy |
|
|||||
|
2018
Q3 | $653K | Sell |
|
|||||
|
2018
Q2 | $554K | Sell |
|
|||||
|
2018
Q1 | $570K | Buy |
|
|||||
|
2017
Q4 | $581K | Buy |
|
|||||
|
2017
Q3 | $573K | Sell |
|
|||||
|
2017
Q2 | $822K | Sell |
|
|||||
|
2017
Q1 | $838K | Buy |
|
|||||
|
2016
Q4 | $707K | Sell |
|
|||||
|
2016
Q3 | $759K | Buy |
|
|||||
|
2016
Q2 | $780K | Buy |
|
|||||
|
2016
Q1 | $636K | Buy |
|
|||||
|
2015
Q4 | $487K | Buy |
|
|||||
|
2015
Q3 | $474K | Buy |
|
|||||
|
2015
Q2 | $467K | Sell |
|
|||||
|
2015
Q1 | $498K | Buy |
|
|||||
|
2014
Q4 | $446K | Buy |
|
|||||
|
2014
Q3 | $408K | Sell |
|
|||||
|
2014
Q2 | $413K | Buy |
|
|||||
|
2014
Q1 | $434K | Buy |
|
|||||
|
2013
Q4 | $323K | Buy |
|